Fate Therapeutics, Inc. (FATE) ownership: Top institutional holder: Redmile Group, LLC ($15.45M). Insider activity: Net Seller (0 buys, 20 sells). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Redmile Group, LLC | 12872946.00 | $15.45M | 2026-03-31 |
| BlackRock, Inc. | 10068614.00 | $12.08M | 2026-03-31 |
| VANGUARD GROUP INC | 8971347.00 | $8.82M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4192063.00 | $5.03M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4134585.00 | $4.96M | 2026-03-31 |
| ACADIAN ASSET MANAGEMENT LLC | 4120200.00 | $4.94M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 3466786.00 | $4.16M | 2026-03-31 |
| JOHNSON & JOHNSON | 3379064.00 | $4.05M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 |
Back to FATE overview · FATE earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.